Curetis N.V. | |
Stock Exchange | Euronext - Alternext Amsterdam |
EPS |
EUR1.41 |
Market Cap |
EUR17.31 M |
Shares Outstanding |
22.57 M |
Public Float |
8.03 M |
Curetis N.V. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
16.39 M |
Public Float |
- |
Address |
Max-Eyth-Strasse 42 Holzgerlingen Baden Wuerttemberg 71088 Germany |
Employees | - |
Website | http://www.curetis.com |
Updated | 07/08/2019 |
Curetis NV engages in the manufacture, research and development, and commercialization of molecular microbiology solutions. It offers unyvero platform, which comprsises of the unyvero system with the A50 analyzer at its core, proprietary software, and single-use, application-specific cartridges. The company was founded by Johannes Bacher, Gerd Luedke and Andreas Boos on October 8, 2015 and is headquartered in Holzgerlingen, Germany. |